Takayanagi R, Ohnaka K, Takasaki C, Ohashi M, Nawata H
Third Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
J Cardiovasc Pharmacol. 1991;17 Suppl 7:S127-30. doi: 10.1097/00005344-199100177-00034.
To characterize the properties and the distribution of endothelin (ET) receptor subtypes, we have examined the ligand selectivity and the molecular weight (Mr) of [125I]ET-1 and [125I]ET-3 binding sites in various tissues of human and pigs. ET-1 and ET-2 showed almost identical potencies in displacing the bound [125I]ET-1 in all of the tissues examined. ET-3, sarafotoxin S6b (SRTX-b), and sarafotoxin S6C (SRTX-c) displaced the [125I]ET-1 with nearly the same sensitivity as ET-1 (IC50 = 0.07-3.0 nM) in brain, kidney, liver, and adrenal, whereas the three peptides showed very weak competition (IC50 = 40-500 nM) against [125I]ET-1 binding in atria, aorta, lung, stomach, and uterus. The Bmax value for [125I]ET-3 was 83% of that for [125I]ET-1 in human liver membranes, whereas the Bmax for [125I]ET-3 was only 12% of that for [125I]ET-1 in human atrial membranes. [125I]ET-3 bound to liver and atrial membranes was displaced by ET/SRTX isopeptides almost equipotently. Two proteins with Mr of 110 and 50 kDa were specifically affinity-labeled with [125I]ET-1 in porcine lung membranes. The above findings indicated that two distinct subclasses of ET receptors, namely ET-1/ET-2-specific and ET/SRT family common receptors, were distributed in various proportions in mammalian tissues.
为了表征内皮素(ET)受体亚型的特性和分布,我们检测了人及猪的各种组织中[125I]ET-1和[125I]ET-3结合位点的配体选择性和分子量(Mr)。在所有检测的组织中,ET-1和ET-2在置换结合的[125I]ET-1时表现出几乎相同的效力。在脑、肾、肝和肾上腺中,ET-3、芋螺毒素S6b(SRTX-b)和芋螺毒素S6C(SRTX-c)置换[125I]ET-1的敏感性与ET-1几乎相同(IC50 = 0.07 - 3.0 nM),而这三种肽对心房、主动脉、肺、胃和子宫中[125I]ET-1结合的竞争作用非常弱(IC50 = 40 - 500 nM)。在人肝细胞膜中,[125I]ET-3的Bmax值是[125I]ET-1的83%,而在人心房膜中,[125I]ET-3的Bmax仅为[125I]ET-1的12%。ET/SRTX异肽几乎等效地置换了结合在肝和心房膜上的[125I]ET-3。在猪肺膜中,两种分子量分别为110 kDa和50 kDa的蛋白质被[125I]ET-1特异性亲和标记。上述发现表明,ET受体的两个不同亚类,即ET-1/ET-2特异性受体和ET/SRT家族共同受体,以不同比例分布于哺乳动物组织中。